初次全膝关节置换术后KOOS疼痛、功能和关节置换评分的实质性临床获益阈值
该回顾性研究基于15,638例初次全膝关节置换患者,计算术后1年KOOS疼痛、物理功能简表(PS)和关节置换(JR)子量表的实质性临床获益(SCB)阈值,分别为33、16和23分,仅59%患者达到。年龄较大、非白人、合并症指数高、商业保险和低教育水平与未达到SCB相关。
要点
- KOOS疼痛、PS和JR子量表1年SCB阈值分别为33、16和23分(满分100)。
- 仅59%(6483例)患者达到上述SCB阈值。
- 年龄较大、非白人、高CCI、商业保险和低教育水平与未达到SCB相关。
核心结论
- 初次全膝关节置换术后1年KOOS疼痛、PS和JR子量表的SCB阈值分别为33、16和23分,仅59%患者达到。
- 年龄较大、非白人、高合并症指数、商业保险和低教育水平与未达到SCB相关。
研究设计与样本
- 回顾性分析多站点三级医疗系统纵向维持的机构登记数据库,纳入2016年至2022年15,638例初次全膝关节置换患者。
- 89%(13,850例)完成基线PROMs,79%(10,988例)完成1年随访并纳入分析。
- SCB阈值采用锚定法计算,锚点为术后1年VR-12第8项,以约登指数最大化为最优阈值。
- 多变量逻辑回归识别未达到SCB的相关因素。
主要发现
- KOOS疼痛SCB阈值为33分(敏感度0.80,特异度0.53,AUC 0.72),KOOS PS为16分(敏感度0.82,特异度0.47,AUC 0.69),KOOS JR为23分(敏感度0.82,特异度0.51,AUC 0.72)。
- 每个子量表均有59%(6483例)患者达到SCB。
- KOOS疼痛未达到SCB的相关因素:年龄较大(OR 0.84 [95%CI 0.78-0.9];p<0.001)、非白人(OR 1.7 [95%CI 1.59-1.93];p<0.001)、较高CCI(OR 1.11 [95%CI 1.05-1.17];p<0.001)、商业保险(OR 0.80 [95%CI 0.72-0.89];p<0.001)。
- KOOS PS未达到SCB的相关因素:年龄较大(OR 0.82 [95%CI 0.76-0.89];p<0.001)、非白人(OR 1.82 [95%CI 1.59-2.1];p<0.001)、较高CCI(OR 1.08 [95%CI 1.02-1.15];p<0.01)、商业保险(OR 0.77 [95%CI 0.68-0.87];p<0.001)、较低教育水平(OR 0.89 [95%CI 0.83-0.96];p<0.01)。
- KOOS JR未达到SCB的相关因素:年龄较大(OR 0.84 [95%CI 0.78-0.90];p<0.001)、非白人(OR 1.77 [95%CI 1.56-2.01];p<0.001)、较高CCI(OR 1.07 [95%CI 1.01-1.12];p=0.01)、商业保险(OR 0.8 [95%CI 0.72-0.90];p<0.001)、较低教育水平(OR 0.92 [95%CI 0.86-0.98];p<0.01)。
关键数值与推荐
- KOOS疼痛SCB阈值为33分(满分100),敏感度0.80,特异度0.53,AUC 0.72。
- KOOS PS SCB阈值为16分(满分100),敏感度0.82,特异度0.47,AUC 0.69。
- KOOS JR SCB阈值为23分(满分100),敏感度0.82,特异度0.51,AUC 0.72。
- 59%(6483例)患者达到各子量表SCB阈值。
临床怎么用
- 研究结果可为全膝关节置换术后患者达到疼痛和功能改善的围手术期支持提供指导。
- 在CMS新PROM政策实施前,识别未达到SCB的高风险人群(年龄较大、非白人、低教育水平、合并症复杂)有助于针对性干预。
局限性
- 本研究为回顾性分析,可能存在选择偏倚和信息偏倚。
- 种族由自我报告确定,仅分为白人和非白人。
- SCB阈值基于单一锚定问题和特定人群,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Centers for Medicare & Medicaid Services (CMS) have mandated the collection of patient-reported outcome measures (PROMs) for inpatient TKA with a submission deadline of September 2025. Not achieving a 20-point improvement in substantial clinical benefit (SCB) on the Knee Injury and Osteoarthritis Outcome Score (KOOS) for joint replacement (JR) will negatively impact hospital reimbursement. However, SCB thresholds for KOOS subscales and factors associated with not achieving SCB remain poorly defined. QUESTIONS/PURPOSES: We retrospectively analyzed a large TKA database at a multisite tertiary healthcare system and asked: (1) What are the SCB thresholds for the KOOS pain, physical function short form (PS), and JR subscales at 1 year after primary TKA? (2) What patient factors are associated with failure to achieve the SCB on these KOOS subscales? METHODS: This was a retrospective analysis of a longitudinally maintained institutional registry, which evaluated the results of 15,638 patients who underwent primary TKA from 2016 to 2022. Of these, 89% (13,850) of patients completed baseline PROMs, and 79% (10,988 of 13,850) of patients completed 1-year follow-up; data from those patients were used in this analysis. Demographics, comorbidities, as well as baseline and 1-year KOOS scores were recorded. The median (IQR) age of these patients was 67 years (61 to 73), 60% (6615 of 10,988) of patients were women, and the median (IQR) BMI was 31.0 kg/m 2 (27.2 to 35.5). The SCB thresholds were calculated using anchor-based methodology, utilizing item 8 from the Veterans RAND 12-Item Health Survey at 1 year postoperatively as an anchor question: "Compared to one year ago, how would you rate your physical health in general now?" The optimal threshold, defined as the value that maximized the Youden index, was used as the SCB threshold to distinguish patients who had substantially improved in terms of end point versus those who had not. Multivariable logistic regression identified factors that were associated with not achieving the SCB. It should be noted that race was identified by self-report and grouped as White and non-White per our database. RESULTS: The SCB thresholds were 33 of 100 for KOOS pain (sensitivity 0.80, specificity 0.53, area under the receiver operating characteristic curve [AUC] 0.72), 16 of 100 for KOOS PS (sensitivity 0.82, specificity 0.47, AUC 0.69), and 23 of 100 for KOOS JR (sensitivity 0.82, specificity 0.51, AUC 0.72), achieved by 59% (6483) of patients for each subscale. For KOOS pain, factors associated with not achieving the SCB included older age (OR 0.84 [95% confidence interval (CI) 0.78 to 0.9]; p < 0.001), non-White race compared with White race (OR 1.7 [95% CI 1.59 to 1.93]; p < 0.001), a higher Charlson comorbidity index (CCI) (OR 1.11 [95% CI 1.05 to 1.17]; p < 0.001), and commercial insurance (OR 0.80 [95% CI 0.72 to 0.89]; p < 0.001). For KOOS PS, factors associated with not achieving the SCB included older age (OR 0.82 [95% CI 0.76 to 0.89]; p < 0.001), non-White race (OR 1.82 [95% CI 1.59 to 2.1]; p < 0.001), a higher CCI (OR 1.08 [95% CI 1.02 to 1.15]; p < 0.01), commercial insurance (OR 0.77 [95% CI 0.68 to 0.87]; p < 0.001), and lower education level (OR 0.89 [95% CI 0.83 to 0.96]; p < 0.01). For KOOS JR, factors associated with not achieving the SCB included older age (OR 0.84 [95% CI 0.78 to 0.90]; p < 0.001), non-White race (OR 1.77 [95% CI 1.56 to 2.01]; p < 0.001), a higher CCI (OR 1.07 [95% CI 1.01 to 1.12]; p = 0.01), commercial insurance (OR 0.8 [95% CI 0.72 to 0.90]; p < 0.001), and lower education level (OR 0.92 [95% CI 0.86 to 0.98]; p < 0.01). CONCLUSION: As TKA outcomes are increasingly judged by achievement of the 20-point SCB threshold on the KOOS JR under new CMS policies, determining SCB thresholds is of utmost importance. This study found SCB thresholds of 33 for KOOS pain, 16 for KOOS PS, and 23 for KOOS JR, with only 59% (6483) of patients achieving these thresholds 1 year after TKA. More at-risk populations, including older, non-White, less educated, and patients with medically complex conditions, were at higher risk of not achieving the SCB. These results suggest that SCB nonattainment after TKA is likely found in a meaningful subset of patients-especially those with greater baseline symptom burden and medical complexity. These findings can guide perioperative support to increase the likelihood that all patients achieve the reduction in pain and improvement in function that they seek from arthroplasty, as healthcare systems prepare for the implementation of the new PROM policy for TKA from the CMS. LEVEL OF EVIDENCE: Level III, Therapeutic study.
引用
- Elmenawi KA, Pasqualini I, Khan ST, et al. What Are the Substantial Clinical Benefit Thresholds for KOOS Pain, Physical Function, and Joint Replacement Scores After Primary TKA? Clin Orthop Relat Res. 2026. PMID: 42328725. doi:10.1097/CORR.0000000000003966
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。